Meningococcal B Vaccine in Patients with Asplenia

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Splenectomy; Status

Interventions

BIOLOGICAL

Bexsero

two doses of Bexsero are applied intramuscularly with a one-month interval between doses

Trial Locations (1)

RECRUITING

Medical University Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER